← FDA Drug Approvals (Drugs@FDA)
REZVOGLAR
BLA · Biologics License Application · Sponsor: ELI LILLY CO · Approved 2022-11-16
Drug application
- FDA Application #
BLA761215- Application type
- Biologics License Application
- Brand name
- REZVOGLAR
- Generic name
- INSULIN GLARGINE-AGLR
- Active ingredients
- INSULIN GLARGINE-AGLR
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ELI LILLY CO
- Manufacturer
- Eli Lilly and Company
- First approval
- 2022-11-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown